AHN, Baylor Scott & White, and Johns Hopkins researchers confirm effectiveness of new immunotherapy drug combination for gastroesophageal cancer treatment

'Nature Medicine' study, published this week, shows immune checkpoint inhibitor drug therapy, followed by traditional cancer treatment and tumor removal, improved patient survival rates for one of the world's deadliest cancers PITTSBURGH, March 19, 2024 /PRNewswire-PRWeb/ -- Researchers...